Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLS-1027 for prevention of severe pneumonitis in COVID-19
2021-002730-16Phase 2Completed
- Sponsor
- GeneOne Life Science, Inc.
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of zenuzolac in coronavirus disease 2019 (COVID-19) and alveolitis, sponsored by GeneOne Life Science, Inc. Primary endpoint: Treatment failure (WHO level ≥ 6). Started Aug 2021; status: completed.
02
Drugs
zenuzolac
03
Conditions
coronavirus disease 2019 (COVID-19)alveolitis
Beyond the preview
Go deeper on 2021-002730-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002730-16.